Comparison
Why is MaxCyte, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -185.46% of over the last 5 years
- INVENTORY TURNOVER RATIO(HY) Highest at 1.32 times
- OPERATING PROFIT(Q) Highest at USD -5 MM
- OPERATING PROFIT MARGIN(Q) Highest at -51.82 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -46.28%, its profits have risen by 11.5%
3
High Institutional Holdings at 89.73%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 13.08% over the previous quarter.
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -46.28% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to MaxCyte, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is MaxCyte, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
MaxCyte, Inc.
-46.28%
-1.02
74.72%
S&P 500
20.78%
1.56
13.28%
Quality key factors
Factor
Value
Sales Growth (5y)
-0.64%
EBIT Growth (5y)
-185.46%
EBIT to Interest (avg)
-37.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
89.73%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.43
EV to EBIT
0.66
EV to EBITDA
0.74
EV to Capital Employed
-0.41
EV to Sales
-0.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-21.20%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Bearish
Technical Movement
12What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 1.32 times
OPERATING PROFIT(Q)
Highest at USD -5 MM
OPERATING PROFIT MARGIN(Q)
Highest at -51.82 %
PRE-TAX PROFIT(Q)
Highest at USD -4.75 MM
NET PROFIT(Q)
Highest at USD -4.75 MM
EPS(Q)
Highest at USD -0.04
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for MaxCyte, Inc.
Inventory Turnover Ratio
Highest at 1.32 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Operating Profit
Highest at USD -5 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -51.82 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -4.75 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -4.75 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)






